Sebastien Gouin
11Patents
2h-index
29Co-inventors
54Inventor score
Filing activity: Oct 16, 1997 → Aug 22, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8337923B2 | Encapsulated antimicrobial material | Emerging Cross-Sectional Technologies | 10 | Active |
| US5955068A | Biodegradable polanhydrides derived from dimers of bile acids, and use thereof as controlled drug release systems | Human Necessities | 6 | Expired |
| US10271557B2 | Composition comprising a bacteriocin and an extract from a plant of the Labiatae family | Emerging Cross-Sectional Technologies | 1 | Active |
| US10632135B2 | Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US8936801B2 | Retention of PBO in polymer matrices by phthalocyanines | Human Necessities | 0 | Active |
| US10273313B2 | Multimeric mannosides, a process for preparing the same and their uses as a drug | Emerging Cross-Sectional Technologies | 0 | Active |
| US8906400B2 | Insecticidal polymer matrix comprising PBO and DM | Human Necessities | 0 | Active |
| US10485811B2 | Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US10111430B2 | Insecticidal polymer matrix comprising PBO and DM | Human Necessities | 0 | Active |
| US10543223B2 | Mannose derivatives useful for treating pathologies associated with adherent E. coli | Emerging Cross-Sectional Technologies | 0 | Active |
| US11389466B2 | Multivalent fucose derivatives for use as a drug | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.